Clinical Assessment of Low Oestrogen Combined Oral Contraceptive
- 19 May 1973
- Vol. 2 (5863) , 389-392
- https://doi.org/10.1136/bmj.2.5863.389
Abstract
Results of experience with a low-oestrogen combined contraceptive in 1,085 women showed that a dosage of less than 50 μg is compatible with satisfactory cycle control and efficacy. The preparation used in the trial, which contained 0·5 mg dl-norgestrel and 0·03 mg ethinyloestradiol, proved acceptable to most of the women.Keywords
This publication has 2 references indexed in Scilit:
- A Placebo-Controlled Double-Blind Crossover Investigation of the Side Effects Attributed to Oral ContraceptivesFertility and Sterility, 1971
- Menstrual Blood Loss–A Population StudyActa Obstetricia et Gynecologica Scandinavica, 1966